n-butyltriphenylammonium bromide | 16131-23-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: n-butyltriphenylammonium bromide
• 英文别名: butyltriphenylammonium bromide；Butyl(triphenyl)azanium;bromide
• CAS: 16131-23-0
• 化学式: Br*C₂₂H₂₄N
• 分子量: 382.343
• InChiKey: CSTPZCSXXGVAQX-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  3.46
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  manganese(II) chloride tetrahydrate 、 potassium tris(oxalato)chromate(III) 、 n-butyltriphenylammonium bromide 以 水 为溶剂， 以87%的产率得到
  参考文献：
  名称：

  Synthesis of molecular ferromagnetics [R3R?X]MCr(C2O4)3 (X = N, R = Bun, R? = Prn, Et, Me; X = P, R = Ph, R? = Bun; M = Mn, Fe, Co, Ni, Cu)

  摘要：

  The synthesis, IR spectra, and the temperatures of the transition into a ferromagnetic state (T-c) of layered ferromagnetics [R(3)R'X]MCr(C2O4)(3) (M = Mn, Fe, Co, Cu, and Ni) with the [Ph(3)BuP](+), (Bu(3)R'N](+) (R' = Pr, Et, and Me) cations capable of subsequently changing the distances between metallooxalate layers have been considered. The temperature T-c has been found to be independent of the size of the organic cation. It is believed that the determining factors in the transition to a ferromagnetic state are exchange interactions inside the metallooxalate layer.

  DOI：

  10.1007/bf01430743

文献信息

• [EN] PROCESS FOR THE PREPARATION OF GAMMA AMINO ACIDS AND INTERMEDIATES USED IN SAID PROCESS<br/>[FR] PROCÉDÉ DE PRÉPARATION DE ACIDES AMINÉS GAMMA ET INTERMÉDIAIRES UTILISÉS DANS CE PROCÉDÉ
  申请人：ROYAL COLLEGE OF SURGEONS IE

  公开号：WO2013076225A1

  公开（公告）日：2013-05-30

  The invention relates to the preparation of gamma amino acids of formula (I) and pharmaceutically acceptable salts, solvates and prodrugs thereof, and to intermediates used for their preparation. (formula I) wherein R1 is selected from an alkyl group, an alkenyl group, an alkynyl group and a cycloalkyl group, each of which may be optionally substituted and * denotes a chiral centre. In particular, the present invention provides an efficient synthesis of (S)-pregabalin which is suitable for carrying out on an industrial scale.

  该发明涉及制备公式(I)的γ-氨基酸及其药学上可接受的盐、溶剂合物和前药，以及用于其制备的中间体。(公式I)其中R1选自烷基、烯基、炔基和环烷基，每种基团均可选择性地被取代，*表示一个手性中心。特别是，本发明提供了(S)-普瑞巴林的高效合成方法，适用于工业规模生产。
• Polymerizable composition, optical material comprising the composition and method for producing the material
  申请人：——

  公开号：US20040254258A1

  公开（公告）日：2004-12-16

  A cured matter obtained by polymerizing and curing a polymerizable composition comprising a compound having at least one episulfide in a molecule is reduced in an odor by adding a perfume to the polymerizable composition comprising the compound having at least one episulfide in a molecule. A cloudiness of the lens is removed by raising a purity of sulfur to 98% or more. A reduction in a chlorine content of the sulfur compound described above to 0.1% by weight or less elevates an oxidation resistance and a light fastness of the high refractive index optical material and improves a color tone thereof. An optical product having a high refractive index and a high-degree transparency is provided by subjecting the composition in advance to deaerating treatment at 0 to 100° C. for one minute to 24 hours under a reduced pressure of 0.001 to 50 torr.

  通过聚合和固化至少含有一种环硫醚的化合物的可聚合组合物获得的治愈物质，通过向至少含有一种环硫醚的化合物的可聚合组合物中添加香水来减少其气味。通过将硫的纯度提高到98％或更高，可以消除镜片的混浊。将上述硫化合物的氯含量降低至0.1％或更低可以提高高折射率光学材料的氧化抗性和耐光性，并改善其色调。通过在0至100°C下将组合物事先进行脱气处理，以在0.001至50 torr的减压下持续1分钟至24小时，可提供具有高折射率和高度透明度的光学产品。
• PROCESS FOR THE PREPARATION OF GAMMA AMINO ACIDS AND INTERMEDIATES USED IN SAID PROCESS
  申请人：Royal College of Surgeons in Ireland

  公开号：US20140336412A1

  公开（公告）日：2014-11-13

  The invention relates to the preparation of gamma amino acids of formula (I) and pharmaceutically acceptable salts, solvates and prodrugs thereof, and to intermediates used for their preparation. (formula I) wherein R 1 is selected from an alkyl group, an alkenyl group, an alkynyl group and a cycloalkyl group, each of which may be optionally substituted and * denotes a chiral centre. In particular, the present invention provides an efficient synthesis of (S)-pregabalin which is suitable for carrying out on an industrial scale.

  本发明涉及制备公式(I)的γ-氨基酸及其药学上可接受的盐、溶剂化物和前药，以及用于它们制备的中间体。(公式I)其中R1选自烷基、烯基、炔基和环烷基，每个基团均可选择性地被取代，*表示手性中心。特别地，本发明提供了一种适用于工业规模的(S)-pregabalin的高效合成方法。
• Composition for a resin
  申请人：MITSUBISHI GAS CHEMICAL COMPANY, INC.

  公开号：EP0936233A2

  公开（公告）日：1999-08-18

  A composition comprising a compound having one or more episulfide groups and/or epoxy groups in one molecule and a compound having one or more isocyanate groups and/or thioisocyanate groups in one molecule. The composition for a resin comprising a sulfur-containing compound exhibits an excellent balance between a refractivity index and an Abbe number and has a large impact resistance.

  一种组合物，包含在一个分子中含有一个或多个环硫基团和/或环氧基团的化合物，以及在一个分子中含有一个或多个异氰酸酯基团和/或硫代异氰酸酯基团的化合物。 包含含硫化合物的树脂组合物在折射率和阿贝数之间表现出极佳的平衡，并具有很强的抗冲击性。
• Process for producing a novel resin for optical materials having excellent color tone and transparency
  申请人：MITSUBISHI GAS CHEMICAL COMPANY, INC.

  公开号：EP0950905A2

  公开（公告）日：1999-10-20

  A process for producing a resin used for optical materials which process comprises curing a composition comprising an ultraviolet light absorbent and an epithio compound by polymerization in the presence of a catalyst, wherein amounts of the ultraviolet light absorbent and the catalyst each expressed as parts by weight per 100 parts by weight of the total amount of the epithio compound, the ultraviolet light absorbent and the catalyst satisfy both of the following relations (a) and (b):(a)0.001 ≦ ultraviolet light absorbent ≦ 1. 000(b).0.001 ≦ catalyst ≦ 5.000 Coloration and clouding of the material of a lens obtained by polymerization of an epithio compound caused by addition of an ultraviolet light absorbent can be prevented.

  一种生产光学材料用树脂的工艺，该工艺包括在催化剂存在下通过聚合固化由紫外光吸收剂和表硫基化合物组成的组合物，其中紫外光吸收剂和催化剂的量分别以表硫基化合物、紫外光吸收剂和催化剂总量每100重量份的重量份数表示，满足以下关系(a)和(b)：(a)0.001 ≦ 紫外线吸收剂 ≦ 1. 000(b).0.001 ≦ 催化剂 ≦ 5.000 可防止因添加紫外线吸收剂而使表硫醇化合物聚合得到的镜片材料变色和混浊。